Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The new screenshot adds more record history entries with newer submission dates, while the main study details and page layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:47:00.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    9%
    Check dated 2025-10-05T05:08:03.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.
    Difference
    0.2%
    Check dated 2025-09-28T02:51:07.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top link has been removed.
    Difference
    0.6%
    Check dated 2025-09-13T16:52:33.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.6%
    Check dated 2025-09-06T14:15:43.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content regarding study status and locations.
    Difference
    49%
    Check dated 2025-08-30T11:09:10.000Z thumbnail image

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.